Mobia Medical, Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the clinically validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. The Vivistim System includes an implantable device that stimulates the vagus nerve only when intentionally activated, triggering the release of neuromodulators, including acetylcholine, norepinephrine, and serotonin. Its neuromodulators create a heightened state of plasticity in the brain, such that neural networks can more readily adapt and reform in response to stimuli. The implantable components of the Vivistim System-namely, the implantable pulse generator (IPG) and lead-are implanted through a minimally invasive outpatient procedure that takes approximately 60 minutes.
Ticker SymbolMOBI
Company nameMobia Medical Inc
IPO dateMay 08, 2026
CEOFoust (Richard John)
Number of employees- -
Security typeOrdinary Share
Fiscal year-end- -
Address2802 Flintrock Trace, Suite 226
City
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code78738
Phone
Website
Ticker SymbolMOBI
IPO dateMay 08, 2026
CEOFoust (Richard John)
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data